According to the lawsuit, the victim, a resident of Kentucky, received a cardiac pacemaker/defibrillator combination (an "ICD"). The ICD was attached to his heart with a Sprint Fidelis lead wire system manufactured by Medtronic on March 25, 2005. On June 22, 2006, the lead had to be surgically removed in an emergency procedure after it was found to be "frayed" in the nature of a fracture.
Those patients whose Sprint Fidelis lead fractures must undergo a dangerous surgical procedure to have the wire replaced. The procedure could cause tearing and scarring of the heart and veins through which the Sprint Fidelis lead wire runs. The surgery to replace a defibrillator lead wire is far riskier than having the device itself replaced.
Defibrillator leads are one of the devices most fragile components.
Since the Sprint Fidelis lead was introduced to the market in 2004 it has
become evident that a significant portion of the leads have potentially
fatal defects. Such defects were discussed in an article written by doctors
at The Minneapolis Heart Institute, one of the premier heart institutes in
the world, based on a study of the incidence of lead failures in the Sprint
Fidelis models compared to the Sprint Quattro models. Researchers at The
Minneapolis Heart Institute found that, between September 2004 and February
2007, 583 patients were implanted with Sprint Fidelis Model 6949 leads and
nine patients received other Sprint Fidelis models. During that time, six
patients experienced Sprint Fidelis Model 6949 lead failures. The failed
Sprint Fidelis Model 6949 leads had been implanted by various
electrophysiologists, cardiologists and thoracic surgeons. The average time
to failure was fourteen months (based on a range of four to twenty-three
months). Medtronic first noti
'/>"/>
| SOURCE Parker Waichman Alonso LLP Copyright©2007 PR Newswire. All rights reserved |